VVOS
Vivos Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.13
+2.90%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.14
From 52W high−95.52%
Volume1.13M
Market cap$2.71M
P/E (TTM)—
P/S (TTM)0.1x
Div yield—
Key dataOct 19, 2026
Open
$0.14
From 52W high
−95.52%
Volume
1.13M
Market cap
$2.71M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.6x
P/E (TTM)
—
RSI (14)
31.2
MomentumView details →
1D Return
+2.90%
YTD Return
−93.64%
SummaryUpdated Jun 1, 2026
Vivos Therapeutics, Inc. (NASDAQ:VVOS) is a medical technology company founded in 2016 and based in Highlands Ranch, Colorado. The company went public in December 2020 and specializes in developing non-invasive treatment alternatives for patients suffering from dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring. Vivos has undergone significant strategic transformation since its founding, evolving from a dental-focused distribution model to a medical sleep center partnership approach, while maintaining its core focus on providing alternatives to traditional CPAP therapy for sleep apnea patients.
Similar companies
Latest newsMore news →
Vivos Therapeutics issued 12,000 shares of Series C Convertible Preferred Stock valued at $12 million to SOD Sciences in exchange for 2,907,338 SOD common shares and a 50% interest in the Test and related intellectual property.5d agoVivos Therapeutics, Inc. dismissed Baker Tilly US, LLP as its independent auditor and engaged Haynie & Company as its new independent auditor, effective September 29, 2026.19d ago